894 related articles for article (PubMed ID: 27835987)
1. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Periostin and Mammalian Target of Rapamycin (mTOR) in Locally Advanced Esophageal Squamous Cell Carcinoma.
Jiang Q; Chen J; Zhang B; Niu J; He Y
Med Sci Monit; 2017 Jun; 23():3200-3208. PubMed ID: 28665915
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma.
Kim SH; Chau GC; Jang YH; Lee SI; Pyo S; Um SH
Hum Pathol; 2013 Feb; 44(2):226-36. PubMed ID: 22944293
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
5. Clinical Role of Excision Repair Cross-Complementing 1 Gene Expression in Resected Esophageal Squamous Cell Carcinoma: A Meta-Analysis.
Wang Y; Li J; Shen C; Wu Y; Che G
Dig Dis Sci; 2020 Aug; 65(8):2264-2271. PubMed ID: 31713119
[TBL] [Abstract][Full Text] [Related]
6. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.
Li SH; Chen CH; Lu HI; Huang WT; Tien WY; Lan YC; Lee CC; Chen YH; Huang HY; Chang AY; Lin WC
Surgery; 2015 Mar; 157(3):570-80. PubMed ID: 25726316
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
Wang H; Deng F; Liu Q; Ma Y
Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Li S; Lai Y; Fan J; Shen C; Che G
Clin Exp Med; 2017 May; 17(2):161-174. PubMed ID: 27099933
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological and prognostic significance of mTOR and p-mTOR expression in patients with non-small cell lung cancer: A meta-analysis.
Qiu W; Ren M; Wang C; Fu Y; Liu Y
Medicine (Baltimore); 2022 Dec; 101(51):e32340. PubMed ID: 36595789
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of microvessel density in esophageal squamous cell carcinoma-a systematic review and meta-analysis.
Guo X; Meng X; Liu R
Pathol Res Pract; 2021 Nov; 227():153644. PubMed ID: 34634564
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Li SJ; Huang J; Zhou XD; Zhang WB; Lai YT; Che GW
J Thorac Dis; 2016 Jul; 8(7):1587-600. PubMed ID: 27499947
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Li SH; Huang EY; Lu HI; Huang WT; Yen CC; Huang WC; Chen CH
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1352-9, 1359.e1. PubMed ID: 22841170
[TBL] [Abstract][Full Text] [Related]
15. No significant association between PIK3CA mutation and survival of esophageal squamous cell carcinoma: A meta-analysis.
Ge XQ; Yang YZ; Li SS; Hou L; Ren JL; Yang KP; Fa XE
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):462-468. PubMed ID: 28585132
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation.
Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH
Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of heat shock protein 27 (HSP27) expression in non-small cell lung cancer: a systematic review and meta-analysis.
Li S; Zhang W; Fan J; Lai Y; Che G
Springerplus; 2016; 5(1):1165. PubMed ID: 27512624
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis.
Ping W; Sun W; Zu Y; Chen W; Fu X
Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106
[TBL] [Abstract][Full Text] [Related]
20. Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.
Hasan R; Sharma R; Saraya A; Chattopadhyay TK; DattaGupta S; Walfish PG; Chauhan SS; Ralhan R
BMC Cancer; 2014 Jan; 14():2. PubMed ID: 24383423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
